Identification of Potential Biological Factors Affecting the Treatment of Ticagrelor After Percutaneous Coronary Intervention in the Chinese Population

BACKGROUND: Generally, many individual factors can affect the clinical application of drugs, of which genetic factors contribute more than 20%. Ticagrelor is a new class of receptor inhibitors receptor antagonist of P2Y12 and is used as an antiplatelet agents. But it is not affected by the influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Dongdong, Shi, Xiangfen, Gao, Liping, Wan, Gaobiao, Zhang, Hanjuan, Yang, Yuling, Zhao, Yujie, Sun, Didi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786390/
https://www.ncbi.nlm.nih.gov/pubmed/35082514
http://dx.doi.org/10.2147/PGPM.S338287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786390/
https://www.ncbi.nlm.nih.gov/pubmed/35082514
http://dx.doi.org/10.2147/PGPM.S338287

Ejemplares similares